| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.26 | 3e-05 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-05 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.17 | 0.0004 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0006 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0008 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.17 | 0.0008 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |